èƵ

Everything we know about long covid – including how to reduce the risk

Some people have been living with long covid for five years, but we are still just starting to learn about its exact causes and how best to treat the condition
Someone with long covid having rehabilitation at the Vall d'Hebron hospital in Barcelona, Spain, in June 2020
People with long covid are advised to pace themselves when it comes to being physically active
REUTERS/Nacho Doce

For many people, the covid-19 pandemic feels like a thing of the past. But for those with long covid, it is far from over. Five years on from when covid-19 turned up, those with lingering symptoms still can’t live their lives as they did before.

The emergence of long covid in the first few months of the pandemic sparked an explosion of research into why some people develop persistent symptoms after being infected with the SARS-CoV-2 virus. Half a decade later, there is growing clarity about how common long covid is and its underlying mechanisms. What is less clear is how many people recover and how best to treat it.

The World Health Organization defines long covid as after the initial infection, or that develop after that point with no alternative explanation. The symptoms of long covid are diverse, the most common being fatigue, headaches, brain fog and post-exertional malaise – meaning even small amounts of physical activity can cause severe exhaustion.

Initially, there was a lot of debate about how common long covid is, but now a rough consensus has formed. Around 5 to 6 per cent of people who are infected with SARS-CoV-2 develop long covid, says at the VA St Louis Health Care System in Missouri. While this is lower than some early estimates, “it’s not an insignificant number”, he says. Some people are also more vulnerable, notably women and people .

The risk doesn’t disappear after the first infection, says at the University of Southampton, UK. The first time you catch covid-19 poses the biggest risk, but it still mounts up with subsequent infections, as Alwan and her colleagues of more than 100,000 UK cases.

On the plus side, newer variants of SARS-CoV-2 are less likely to trigger long covid than the ones that circulated earlier in the pandemic. “It’s not the same virus that it was three, four years ago,” says Al-Aly.

In a study published in July last year, he and his colleagues found that the in unvaccinated people from when the early alpha variant was circulating to when it was replaced by delta and omicron. “There’s a clear decline in the risk and burden of long covid as a function of the changes in SARS-CoV-2 itself,” says Al-Aly.

It is also clear that covid-19 vaccines lower the risk. There is some debate about the scale of this reduction, says Al-Aly. But, “I haven’t seen a credible study that suggests that the vaccines don’t reduce the risk of long covid”, he says.

What is less clear is how many people recover from long covid or how long it takes. “I don’t really think we have a proper definition [of recovery],” says Alwan. Does it mean having no symptoms at all, and if so for how long, or does it mean being able to return to your previous lifestyle even if you still have mild symptoms? Some researchers have attempted to , but used conflicting definitions of recovery. “It’s a mess,” says Al-Aly.

Crucially, many people with long covid report that their symptoms ease, sometimes for weeks or months, then return. This must be factored in, says Alwan. “We could possibly talk about it more in terms of remission.”

To learn more about recovery, we need much more clarity about the underlying causes of long covid. “There are multiple mechanisms at play,” says Al-Aly, which helps explain why long covid’s symptoms are .

In at least some cases, SARS-CoV-2 persists in the body. Early in the pandemic, this was widely believed to be unlikely. However, at the Icahn School of Medicine at Mount Sinai in New York says there have now been many well-conducted studies showing that entire viruses, or , can remain in various .

In a study published in October last year, Putrino and his colleagues found that molecules called antigens from the virus could be detected in people’s blood up to 14 months , and this was more common in those with long covid. The question now is why this leads to symptoms – and why some people are unaffected.

Additional infections may also contribute to the risk. Viruses like and linger in the body , “not really causing much trouble”, says Putrino, but covid-19 somehow . “All of a sudden, you’ve got symptoms,” he says. “Previously latent pathogens are reactivating.”

Other mechanisms see the body . One much-discussed finding is that people with long covid appear to be , often having tiny microclots in their bloodstream that could block smaller blood vessels, causing or damaging vessel walls. This could be due to the immune system misfiring in some way or it may be a consequence of the virus persisting in the body. If the latter, treating clotting may ease some symptoms, but won’t eradicate the virus or cure long covid.

Long covid is also strongly associated with disruptions of the immune system. Evidence has accumulated around the importance of autoantibodies, which cause the immune system to attack the body.

Last year, in a study that wasn’t peer-reviewed, Putrino and his colleagues found that people with long covid had higher levels of autoantibodies, and those with neurological symptoms had nervous system proteins. When the team transferred immune proteins from these people into mice, the animals became less able to balance or coordinate their movements, mirroring the dizziness experienced by the participants.

A group that included Rob Wüst at VU Amsterdam in the Netherlands reported in a preliminary study in May. “Most likely, one of the pathological drivers there is a functional autoantibody,” says Putrino.

Some of the fatigue that marks long covid may be due to a literal energy shortage. Our cells contain mitochondria, which supply energy. “There is some form of mitochondrial dysfunction happening in people with long covid,” says Al-Aly. Last year, Wüst’s team reported in people with long covid-related post-exertional fatigue, which indicated that their mitochondria weren’t working properly.

Like with many conditions, the gut microbiome could also play a role. The idea is that when we get sick with covid-19, so do the microorganisms in our gut, says Al-Aly. “Maybe they don’t fully recover, and then when they don’t recover, we don’t really recover.” He calls it “a less-accepted hypothesis”, but points out that a 2023 randomised controlled trial found that a daily cocktail of symptoms. “So there may be something to it,” he says.

What does all this mean for people who have long covid? If they have access to healthcare, they should be offered treatments that tackle their symptoms. For instance, people with heart palpitations may be given beta blockers. They could also be recommended lifestyle interventions. “Pacing is widely recommended for long covid – doing what you can within your energy level,” says Alwan.

However, there is no treatment that tackles the root cause or causes. Not a single medication has been approved in either the US or the European Union, which Al-Aly calls “a major collective failure”.

Part of the problem is that the US National Institutes of Health allocated most of its long covid funding to observational studies, holding little back for randomised-controlled trials, says Al-Aly. “Now they’re trying to play catch-up.”

Many treatments are being tested, with Al-Aly, Putrino and Alwan all being involved in such trials. However, Al-Aly and Putrino both say that long covid requires a different approach to testing.

Traditional trials that focus inflexibly on one treatment will take too long, because there are so many potential therapies to sort through and long covid is so diverse. If researchers stick to the traditional paradigm, we will be in the same position on the 10th anniversary of covid-19, says Al-Aly.

Instead, he and Putrino want to do adaptive trials, in which multiple treatments are offered and people can change therapies during the study, which has been done in cancer and cardiology research. “The concept is not new,” says Al-Aly.

Healthcare and public health systems also to better handle conditions like long covid. “We need to have proper frameworks for these infection-induced non-communicable diseases,” says Alwan. This could include rules around ventilation to reduce transmission and introducing care teams that provide a range of treatments and support.

“There’s going to be another pandemic,” says Al-Aly. “We just don’t know when and what.” Like with covid-19, that infection could also cause lingering symptoms. To understand the causes of post-infection complications, and avoid widespread ill health, Al-Aly wants to see more focus on long covid, not just SARS-CoV-2 itself: “How do we best optimise our response to ‘long virus 2030’?”

Read more in our

Topics: covid-19 / long covid